Schmidt, A.; Behrendt, L.; Eybe, J.; Warmann, S.W.; Schleicher, S.; Fuchs, J.; Schmid, E.
The Effect of Direct and Indirect EZH2 Inhibition in Rhabdomyosarcoma Cell Lines. Cancers 2022, 14, 41.
https://doi.org/10.3390/cancers14010041
AMA Style
Schmidt A, Behrendt L, Eybe J, Warmann SW, Schleicher S, Fuchs J, Schmid E.
The Effect of Direct and Indirect EZH2 Inhibition in Rhabdomyosarcoma Cell Lines. Cancers. 2022; 14(1):41.
https://doi.org/10.3390/cancers14010041
Chicago/Turabian Style
Schmidt, Andreas, Lucas Behrendt, Jana Eybe, Steven W. Warmann, Sabine Schleicher, Joerg Fuchs, and Evi Schmid.
2022. "The Effect of Direct and Indirect EZH2 Inhibition in Rhabdomyosarcoma Cell Lines" Cancers 14, no. 1: 41.
https://doi.org/10.3390/cancers14010041
APA Style
Schmidt, A., Behrendt, L., Eybe, J., Warmann, S. W., Schleicher, S., Fuchs, J., & Schmid, E.
(2022). The Effect of Direct and Indirect EZH2 Inhibition in Rhabdomyosarcoma Cell Lines. Cancers, 14(1), 41.
https://doi.org/10.3390/cancers14010041